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Abstract 
Background: An isochromosome of the long arm of chromosome 7, i(7)(q10), and an interstitial deletion of the long 
arm of chromosome 20, del(20)(q), are the most frequent anomalies in the bone marrow of patients with Shwach-
man-Diamond syndrome, which is caused in most cases by mutations of the SBDS gene. These clonal changes imply 
milder haematological symptoms and lower risk of myelodysplastic syndromes and acute myeloid leukaemia, thanks 
to already postulated rescue mechanisms.
Results: Bone marrow from fourteen patients exhibiting either the i(7)(q10) or the del(20)(q) and coming from two 
large cohorts of patients, were subjected to chromosome analyses, Fluorescent In Situ Hybridization with informative 
probes and array-Comparative Genomic Hybridization. One patient with the i(7)(q10) showed a subsequent clonal 
rearrangement of the normal chromosome 7 across years. Four patients carrying the del(20)(q) evolved further differ-
ent del(20)(q) independent clones, within a single bone marrow sample, or across sequential samples. One patient 
with the del(20)(q), developed a parallel different clone with a duplication of chromosome 3 long arm. Eight patients 
bore the del(20)(q) as the sole chromosomal abnormality. An overall overview of patients with the del(20)(q), also 
including cases already reported, confirmed that all the deletions were interstitial. The loss of material varied from 1.7 
to 26.9 Mb and resulted in the loss of the EIF6 gene in all patients.
Conclusions: Although the i(7)(q) and the del(20)(q) clones are frequent and clinically benign in Shwachman 
Diamond-syndrome, in the present work we show that they may rearrange, may be lost and then reconstructed de 
novo, or may evolve with independent clones across years. These findings unravel a striking selective pressure exerted 
by SBDS deficiency driving to karyotype instability and to specific clonal abnormalities.
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Background
Shwachman-Diamond syndrome (SDS) is an autosomal 
recessive disorder (Online Mendelian Inheritance in Man 
#260400) characterized by exocrine pancreatic insuffi-
ciency, bone marrow failure, peripheral cytopenias and 
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an increased risk of developing aplastic anaemia, myelo-
dysplastic syndrome (MDS) and acute myeloid leukaemia 
(AML). The patients may also exhibit several additional 
signs. SDS is caused by mutations of the SBDS gene in 
at least 90% of cases. [1] SBDS protein has been associ-
ated with different functions, mainly playing a role in 
ribosome biogenesis or RNA processing [2] and, as other 
genes belonging to this group, it is highly conserved in all 
eukaryotes [1, 3]. Recently, it has been well characterized 
that SBDS protein play a pivotal role in the early ribo-
some biogenesis by releasing the anti-association factor 
EIF6 from the pre-60S ribosome subunit thus allowing 
the formation of the mature 80S ribosome [4]. However, 
SDS is genetically heterogeneous. Biallelic mutations of 
two other genes involved in ribosome biogenesis may 
cause SDS, or an SDS-like condition: DNAJC21,[5, 6] 
and EFL1 [7]. An SDS-like phenotype may be also caused 
by monoallelic mutations of the gene SRP54, which pro-
duces a protein that is a key member of the cotranslation 
protein-targeting pathway [8]. Therefore, SDS may be 
considered a ribosomopathy.
Clonal chromosome changes are often found in the 
bone marrow (BM) of patients with SDS. Among them, 
the most frequently observed clonal abnormalities are 
an isochromosome of the long arm of chromosome 7, 
i(7)(q10), and an interstitial deletion of the long arm of 
chromosome 20, del(20)(q) [9]. We have already shown 
those molecular mechanisms underlying the fact that 
both these more frequent anomalies are benign prognos-
tic signs, as they are not associated with leukemia pro-
gression. The i(7)(q10) results in duplication of mutation 
c.258 + 2 T > C of the SBDS gene, which is a hypomorphic 
mutation that allows the production of a scant amount 
of functional protein [10]. The del(20)(q) results in dele-
tion of the EIF6 gene [11, 12]. Both these anomalies are 
predicted to result in more efficient ribosome biogenesis 
in the BM abnormal clone which may lower the risk of 
MDS/AML [10, 11] and result in a milder haematological 
condition compared to SDS patients with other chromo-
some changes or with normal karyotype [13–15]. These 
conclusions were further supported by a recent paper 
concerning the benign effects of somatic mutations of 
EIF6 [16].
We have demonstrated that SDS is not associated 
with an increase of spontaneous chromosome breaks, 
as in customary breakage syndromes, a possibility that 
was raised by some previously published reports [17]. 
Nevertheless, we suggested since 2000 that SDS may be 
associated with a particular type of karyotype instability 
resulting in specific anomalies of chromosomes 7 and 20: 
i(7)(q10) and del(20)(q) [18].
We present here an updated overview of available cases 
with del(20)(q) from a cohort of patients in whom the 
deletion was defined precisely by array-based compara-
tive genomic hybridization (a-CGH) and fluorescence 
in  situ hybridization (FISH). These findings support the 
notion that the selection pressures exerted by SBDS defi-
ciency result in specific karyotype instability (confirmed 
by some novel data presented here) and recurrent clonal 
abnormalities.
Results
The only patient considered here with the i(7)(q10), 
patient 10, later acquired also a deletion of the short arm 
of chromosome 7 (Table  1, Fig.  1), which was demon-
strated by FISH as present in a clone without the isoch-
romosome. Figure  1a shows the a-CGH profile of the 
i(7)(q10) in BM samples obtained in 2009 and 2017. An 
enlarged view of the short arm telomeric region from 
the sample obtained in 2017 demonstrates the deleted 
segment (Fig.  1b). FISH analysis demonstrates that the 
clones with the i(7)(q10) and with the del(7)(p21.3pter) 
are independent (Fig. 1c, d and e).
The del(20)(q) was defined precisely by a-CGH and 
FISH in the 13 patients in whom it was initially noted on 
chromosomal karyotype analysis. Eight patients mani-
fested the del(20)(q) as their sole chromosomal anomaly. 
The positions of the deletion breakpoints, together with 
the proportion of cells harboring the deletion are listed 
in Table  2. The a-CGH profiles of six of these patients 
are shown in Fig. 2a. Table 2 includes also the two cases 
(11 and 12) in whom the paucity of BM abnormal cells 
did not allow the a-CGH study, and the result derives 
only from FISH on interphase nuclei (Fig.  2b and c). In 
particular, we observed 18/321 (5.6%) and 9/309 (2.9%) 
nuclei with the deletion of chromosome 20 in patient 11 
and 12, respectively. FISH on nuclei of normal healthy 
control gave 100% of normal signals for both probes as 
control. It is possible that the FISH results in these two 
patients could also indicate a clone with monosomy 20, 
but we interpreted our findings as due to an interstitial 
deletion because during standard chromosome analyses 
across years, we always found a clone with the interstitial 
deletion of chromosome 20, del(20)(q), but never a mon-
osomy 20. The dimension of the deletion of these two 
patients is at least of about 7  Mb according to the seg-
ment spanning the two probes used (Table 2),
Five patients with the del(20)(q), showed more than 
one abnormal clone, either simultaneously in a single BM 
sample (cases 2, 4, and 13), or sequentially in two sam-
ples drawn in different years (cases 9 and 14). The results 
concerning these patients are summarized in Table 1. The 
percentage of abnormal cells in Tables 1 and 2 was calcu-
lated from a-CGH data as previously described [19].
The results for each patient with more than one abnor-
mal clone were further analyzed. The a-CGH profile 
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of patient 2 (Table  1, Fig.  3c) showed in the same BM 
sample not only a large deletion in 43% of the cells but 
also a second clone with a smaller deletion, inside the 
region of the first one, in 23% of the cells. The overall 
percentage of abnormal cells became 66% for this smaller 
segment. Patient 4 showed a large deletion del(20)(q), a 
small duplication of 1.9 Mb, dup(20)(q13.32q13.33), and 
a duplication of the long arm of chromosome 3 (Table 1, 
Table 1 Patients with more than one clonal anomaly in BM, either in the same sample or in samples drawn in different years
Chromosomal anomalies were defined by a-CGH except where noted otherwise. The percentage of abnormal cells is calculated from a-CGH results, except for the  2nd 
clone of patient 13 and the 2019 sample of patient 14
a This percentage refers only to the 2nd clone b The anomalies may be in independent clones or associated in a single clone
c a-CGH results showed monosomy of the entire short arm and trisomy of the entire long arm
d The anomalies were in two independent clones, as shown by FISH (Fig. 1c, d, e)
e Result of chromosome analysis
f Two clones with different del(20)(q), as shown by double color FISH with two different probes identifying different regions of chromosome 20 long arm (Fig. 3 D)
Patient Sample Anomaly 1st clone—bands and DNA bp (% cells) Anomaly 2nd clone—bands and DNA bp (% cells)
2 2009 del(20)(q11.21q13.13) 30,733,183–49,339,757 bp (43%) del(20)(q11.22q11.23) 33,148,327–36,779,644 bp (23%)a
4 2010 del(20)(q11.21q13.13) 31,954,597–49,216,901 bp (17%)b
dup(20)(q13.32–q13.33) 58,349,436–60,320,956 bp (19%)b
dup(3)(q24q29) 143,044,212–195,076,511 bp (34%)b
9 2009 del(20)(q11.21q13.32) 30,876,455–57,739,561 bp (55%) –
2017 – del(20)(q11.21q13.13) 30,904,022–49,344,382 bp (52%)
10 2009 i(7)(q10) (24%)c –
2017 i(7)(q10) (16%)c,d del(7)(p21.3pter) (10%)d
13 2018 del(20)(q11.22q11.23) 32,738,995–34,468,385 bp (35%) del(20)(q11.2q13)e 2 out of 6 mitoses
14 2017 del(20)(q11.21q12) 31,814,242–40,237,993 bp (12%)b
dup(20)(q11.33) 58,725,726–61,314,465 bp (18%)b
–
2019 del(20)(q)f del(20)(q)f
Fig. 1 Profiles of a-CGH of patient 10 in the BM samples drawn in 2009, showing the i(7)(q10), and in 2017 also showing a deletion of the telomeric 
region of the short arm (a), which is more appreciable in an enhanced image (b). Double color FISH with the probes indicated in the figure (one 
located in the short arm, the other in the long arm) shows that two different abnormal clones are present: one with the i(7)(q10) (nucleus with three 
green and two red signals) (d), one without the i(7)(q10) and with the deletion as demonstrated by the mitosis with one normal chromosome 7 and 
a deleted one, with only the green signal (c), and by the nucleus with two green and one red signal (e)
Page 4 of 9Khan et al. Molecular Cytogenetics           (2021) 14:54 
Fig. 3a): these anomalies, found in the same BM sample, 
might be present in the same clone or in independent 
clones. In patient 9, the deletion was defined by a-CGH 
in 2009, but it became shorter in 2017 (Table 1, Fig. 3b), 
consistent with the development of two independent 
clones each with different deletions, possibly at differ-
ent times. Similarly, two clones with different deletions 
of chromosome 20 were identified in patient 13 by com-
paring the results of standard chromosome analyses and 
a-CGH performed in 2018 (Table  1). A large del(20)(q) 
was observed by chromosome analysis (it was already 
identified one year earlier), however, a-CGH showed only 
a very small deletion (the smallest we ever found, 1.7 Mb 
(Table 1, Fig. 3e)). These findings are consistent with the 
presence of two clones with two different deletions, as 
the clone observed by a-CGH was too small to be iden-
tified through chromosome analysis, despite its presence 
in 35% of the cells. On the contrary, the large deletion 
identified at standard chromosome analysis should be 
detectable by a-CGH, but it must be present in a small 
clone, as it escaped identification by this method.
In patient 14, the del(20)(q) was found in 2017, and 
defined by a-CGH, which also gave evidence of a small 
duplication of chromosome 20 of 2.8  Mb, dup(20)
Fig. 2 Patients with del(20)(q) as sole anomaly: a-CGH profiles of six patients (a), and FISH results on nuclei with probes RP11-29E13 (red signal), 
which includes the EIF6 gene, and RP11-17F3 (green), localized in band 20q12. Patient 11, with one single signal of both probes (b), indicating 
a large deletion; Patient 12, with one normal nucleus with two signals of both probes and one nucleus with one signal for both probes (large 
deletion) (c). The precise definition of the deletions is in Table 2
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Fig. 3 Profiles of a-CGH and FISH signals in patients with more than one abnormal clone. The a-CGH profiles of chromosome 20 and chromosome 
3 of patient 4 show a large deletion del(20)(q), a small duplication of the long arm of chromosome 20 and a large duplication of chromosome 3 (a). 
The a-CGH profiles of BM samples from patient 9 drawn in 2009 and 2017 show two distinct sequential clones with deletions of different sizes (b). 
The a-CGH profile of patient 2 shows two overlapping deletions in (20)(q), one larger and one smaller, included in the first one, and both leading 
the loss of the EIF6 gene (c). The double color FISH on nuclei of patient 14 at the BM sample drawn in 2019 (d), with two different probes (indicated 
in the figure), demonstrates that one clone bear a large deletion (loss of both signals, below), and another clone a smaller deletion, losing only the 
region of the EIF6 gene (only one red signal, above). The a-CGH profile of patient 13 with a tiny del(20)(q), and a cut-out of Q-banded chromosomes 
20 in which the deletion, although small, is large enough to be detected (e). The precise delineation of the anomalies is summarized in Table 1
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(q11.33) (Table 1). In 2019, standard chromosome analy-
sis failed to show the deletion, but FISH on nuclei with 
two different probes demonstrated the presence of two 
different deleted clones (Table  1, Fig.  3d), as 4% (9/222 
nuclei) of the cells lost both the signals of the probes 
used, while 6% (13/222 nuclei) lost only the one of the 
probe including the EIF6 gene (Control FISH on nor-
mal donor nuclei gave a 100% of normal signals). Every 
del(20)(q) clonal abnormality resulted in a deletion of the 
EIF6 gene.
Discussion
This study provides a detailed analysis of an additional 
13 SDS patients with del(20)(q) which, taken together 
with the patients previously reported, demonstrate that 
EIF6 is lost in all del(20)(q) clones observed in a total 
of 24/24 patients analyzed until now. Overall, among 
22 of them, the result was reached by means of a-CGH, 
and, in two cases, through FISH analysis with informa-
tive probes (Table 2, Additional File 1: Table S1). It has 
been postulated that del(20)(q), with consistent loss of 
the EIF6 gene in all cases analysed, imply a good prog-
nosis, with lower risk of MDS/AML and milder hae-
matological conditions [11, 13, 15]. The relevance of 
EIF6 protein in ribosome biogenesis [4] may explain the 
benign effects in BM of the deletion del(20)(q) [16]. In 
a study on gene expression in BM of SDS patients with 
del(20)(q), with i(7)(q10), with other clonal anomalies 
or with normal karyotype, the transcription pattern of 
the patients with acquired del(20)(q) was similar to that 
of healthy subjects, at least in cases with a high propor-
tion of abnormal cells, thus supporting the potential 
positive role of this anomaly [20].
Considering all the 24 patients analyzed in the pre-
sent paper or previously reported, and belonging to two 
large different cohorts, our results confirmed that all 
the deletions are interstitial, with proximal breakpoints 
clustered in a region of about 2.6 Mb in bands q11.21-
q11.22, while distal breakpoints were variable (Tables 1 
and 2, Additional File 1: Table  S1). In the majority of 
the cases, the deletion was large enough to be identified 
by standard chromosome analysis (range 14–26.9  Mb 
in 18 out of 24 patients), though smaller deletions 
were detectable only by a-CGH or FISH in a minority 
of cases. Overall, the range of the losses varies from 
1.7  Mb (patient 13) to 26.9  Mb (patient 9) (Table  1, 
Additional File Table S1).
The six patients who showed unexpected clonal 
variations of the anomalies in BM, del(20)(q) in five 
cases, i(7)(q10) in one, either in a single sample, or in 
samples obtained in different years (Table  1) deserve 
a specific comment. We have to remark that, besides 
these six cases, further evidence of peculiar instabil-
ity is offered by three patients already reported (UPN 
17, 20 and 68) [12], in whom the del(20)(q) showed a 
further rearrangement leading to complex independ-
ent subclones (UPN 17 and 20) or two separate dele-
tions with a segment conserved between (UPN 68). 
The molecular basis underlying this mechanism have 
not been clarified yet. A possible hypothesis is that the 
karyotype instability, typical of SDS and demonstrated 
by our findings, may drive to different scenarios: 1) Kar-
yotype instability driving to rearrangements of chro-
mosomes 7 or 20, could have a positive effect for the 
clone that carries the anomaly; this could be related to 
the doubling of the hypomorphic SBDS258+2 T>C muta-
tion on the i(7)(q10) [10] or by deletion of one EIF6 
allele in the del(20)(q) [13], respectively. 2) Karyotype 
instability driving to rearrangements of other chromo-
somes, could be of unknow significance or even have 
potentially negative effects. 3) The karyotype instability 
could continuously act in SDS patients and drive to dif-
ferent independent rearrangements in patients during 
Table 2 Patients with del(20)(q) as sole anomaly in BM: definition of the deletion by a-CGH (patients 1–8) or FISH (patients 11 and 12)
The percentage of abnormal cells is calculated from a-CGH results, except for patients 11 and 12
a Result obtained by double color FISH with the bac probes RP11-17F3 and RP11-29E13: the deletion therefore is at least from 33,797,020 to 40,857,566 bp
b % from FISH results: 1/16 mitoses and 18/321 nuclei
c % from FISH result: 9/309 nuclei
Patient Bands Deletion start (bp) Deletion stop (bp) % Abnormal cells
1 q11.21-q13.13 31,954,597 48,328,296 36%
3 q11.2-q13.2 31,720,622 53,559,811 26%
5 q11.21-q13.13 30,849,566 49,398,586 29%
6 q11.21-q13.13 30,889,915 47,912,299 74%
7 q11.21-q13.13 31,412,080 49,339,757 39%
8 q11.21-q13.32 31,671,222 57,911,624 36%
11 q11.22-q12a – – 5.6%b
12 q11.22-q12a – – 2.9%c
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life span. These latter successive rearrangements can 
further involve chromosomes 7 and 20 (with possible 
benign effects as above) or other chromosomes (with 
unknown significance). The data regarding the six new 
cases presented here, strongly confirm that in the BM 
of SDS patients the karyotype instability is actually pre-
sent and acts mainly on chromosomes 7 and 20, being 
the basis of the recurrent clonal anomalies, through a 
striking selective pressure.
Conclusions
The present paper leads to conclusions concerning two 
points:
We confirm that in all patients with SDS, the del(20)(q) 
in BM imply the loss of the EIF6 gene: the analysis of the 
cases presented here and of those already reported leads 
to a total of 24 patients. This change has specific prog-
nostic benign implications, playing a role as BM rescue 
mechanisms as previously postulated [13, 15, 16, 20].
The patients who bear the i(7)(q10) or the del(20)(q) 
in BM, may rearrange the abnormal clones in the course 
of the disease, or they may loose and then reconstruct 
de novo the deletion, or they may evolve independently 
these clones in other ways. In particular, in 4/6 cases with 
del(20)(q) and unexpected clonal evolution here reported, 
the variated parallel clones involve invariably the chro-
mosome 20, again with the loss of EIF6. In 1/6 cases, the 
patient with the i(7)(q) rearranged independently the 
normal chromosome 7 in a different clone. These findings 
strongly indicate that in SDS patients there is a peculiar 
karyotype instability, depending upon a mechanism/s not 
yet identified, that, through a striking and specific selec-
tive pressure, acts mainly on chromosomes 7 and 20 and 
drives to a somatic rescue of the clone, as recently shown 
by Tan and coworkers for del(20)(q) [16].
Methods
Bone marrow samples were obtained from eight patients 
from the cohort of the North American Shwachman-Dia-
mond Syndrome Registry (SDSR) and from six patients 
from the cohort of the Registro Italiano per la Sindrome 
di Shwachman-Diamond (RI-SDS). In total, samples 
were analyzed from fourteen patients, three females and 
eleven males, with age at the time of sampling for the 
analyses reported here ranging from three to 29  years 
(Table 3). All the patients presented the main typical phe-
notypic signs of SDS. Informed consent for this study was 
obtained according to the principles of the Declaration 
of Helsinki from the patients or the patients’ parents on 
protocols approved by the institutional review boards for 
human subjects research.
Mutational analysis was performed according to Boo-
cock et al. [1] or by sequencing the entire SBDS gene, and 
the mutations of patients are indicated in Table 3. These 
patients were chosen because they bore the more fre-
quent clonal chromosome anomalies in BM, the del(20)
(q) in thirteen patients and the i(7)(q10) in one, which 
were detected by chromosome analysis.
Chromosome analyses were performed on BM by 
QFQ-banding with routine methods. Karyotypes was 
reconstructed by Leica Chantal Software. FISH on BM 
mitoses and nuclei was carried out according to stand-
ard techniques with the BAC probes informative for the 
change detected in each patient: dual color FISH with 
probes RP11-17F3 and RP11-29E13 (Empire Genom-
ics, Williamsville, New York, USA) for patients 9, 11, 12, 
14 and dual color FISH with probes RP11-261N10 and 
CTD-3095D13 (Empire Genomics, Williamsville, New 
York, USA) for Patient 10). The two dual color FISH was 
tested on peripheral blood nuclei from a healthy control 
subject to assess the threshold for the detection of the 
deletion: every probe used, gave 300/300 (100%) normal 
signals in the hybridized nuclei.
The a-CGH was performed on DNA from BM sam-
ples with the 4 × 180 K or 244 K genome-wide system 
(Agilent Technologies Inc., Santa Clara, CA, USA), 
according to the manufacturer’s instructions, as already 
described [21]. Briefly, DNA from BM was extracted 
by Qiagen Flexigene kit (Qiagen, Hilden, Germany). 
The normal reference DNA and the patient’s DNA 
were labelled with Cy5 and Cy3 fluorochromes respec-
tively and purified by the use of SureTag Complete 
Table 3 Patient characteristics
a Patients 1–8 from the cohort of the North American Shwachman-Diamond 
Syndrome Registry (SDSR); patients 9–14 from the cohort of the Registro Italiano 
per la Sindrome di Shwachman-Diamond (RI-SDS)
b Age (years) at time or times of BM sampling
Patient ID a Ageb/sex SBDS mutations
1 6/M c.183_184delTAinsCT/c.258 + 2 T > C
2 4/M c.258 + 2 T > C/c.258 + 2 T > C
3 20/F c.183_184delTAinsCT/c.258 + 2 T > C
4 5/M c.183_184delTAinsCT/c.258 + 2 T > C
5 11/M c.170 T > C/258 + 2 T > C
6 14/M c.258 + 2 T > C/c.258 + 2 T > C
7 29/M c.183_184delTAinsCT/c.258 + 2 T > C
8 16/M c.183_184delTAinsCT/c.258 + 2 T > C
9 11, 19/M c.183_184delTAinsCT + 258 + 2 T > C/258 + 
2 T > C
10 13, 16/F c.183_184delTAinsCT/c.258 + 2 T > C
11 15/F c.183_184delTAinsCT/c.258 + 2 T > C
12 M c.183_184delTAinsCT/c.258 + 2 T > C
13 13, 14/M c.183_184delTAinsCT + 258 + 2 T > C/c.258 
+ 2 T > C
14 3, 5/M c.183_184delTAinsCT + 258 + 2 T > C/c.258 
+ 2 T > C
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DNA Labeling Kit (Agilent Technologies Inc., Santa 
Clara, CA, USA). Labelled DNAs were dissolved into 
the Oligo aCGH/ChIP-on-chip Hybridization solution 
(Agilent Technologies Inc., Santa Clara, CA, USA) in a 
suitable volume for hybridization, according to manu-
facturer’s instructions. Hybridization was performed 
in a rotating oven at 65  °C for 24  h (180  K slides) or 
40 h (240 k slides). Microarray slides were washed with 
Agilent’s Oligo aCGH/ChIP-on-chip solution 1 and 
2 according to manufacturer’s instructions and slides 
images were acquired with Agilent’s G2565CA micro-
array scanner. Features were extracted by Agilent’s Fea-
ture Extraction 12.1.1.1 software and data analysis were 
performed by Agilent’s Genomic Workbench 7.0.4.0 
software. All map positions in the results refer to the 
genome assembly map hg19.
Chromosome, FISH or aCGH analyses were repeated 
in all patients during several years, at least once per year. 
Results of chromosome analysis and a-CGH of patients 
9, 10, and 11 have been previously partially reported [13, 
17, 22].
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